Samantha Bilton

KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition

Sandra Misale, Jackson P. Fatherree, Eliane Cortez et al. · Clinical Cancer Research · 2018 · 267 citations

Medicine, Oncology, Pharmacology +14

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer

Sana Raoof, Iain J. Mulford, Heidie Frisco Cabanos et al. · Oncogene · 2019 · 213 citations · Full text

Medicine, Cancer Biology, Oncology +11

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi et al. · Nature · 2023 · 145 citations · Full text

Medicine, Cancer Biology, Molecular Genetics +12

Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in <i>KRAS</i> -Mutant Non–Small Cell Lung Cancer

Varuna Nangia, Faria M. Siddiqui, Sean Caenepeel et al. · Cancer Discovery · 2018 · 91 citations

Medicine, Oncology, Pharmacology +15

APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer

Hideko Isozaki, Ammal Abbasi, Naveed Nikpour et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 18 citations

Life Sciences, Genetics, Oncology +14